Background: Multiple HIV prevention strategies involving expanded HIV testing and implementation of expanded treatment guidelines, both populationwide and institutionally, have been recently instituted in the catchment area of the Montefiore Medical Center clinical network (MMC), the largest provider of HIV care in the Bronx, New York. We aimed to examine the association between the introduction of these initiatives and improvements in community viral load between 2007 and 2012. Methodology: We used data from the Einstein-Montefiore Center for AIDS Research (CFAR) HIV Integrated Clinical Database, which combines electronic medical records, laboratory test results, prescription data, and clinical intake information. Inclusion criteria included HIV infection, intake at an outpatient clinic affiliated with MMC, age 13+, and at least one HIV-1 viral load (VL) measure obtained during the study period. We described community viral load based on the geometric mean of the last recorded VL per individual in each year, including both those in regular care and those in sporadic care. We examined calendar-year trends in VL suppression (<200 copies/mL) in the population overall and among prespecified subgroups. We assessed disparities in VL suppression by age, sex, race/ethnicity, and transmission risk using Poisson regression with generalized estimating equations. Results: We analyzed 6,998 HIV-infected individuals receiving outpatient care at MMC between 2007 and 2012 (median age 48, interquartile range 41-55, 47% Hispanic, 45% black). The median HIV-1 VL throughout this period was <200 copies/mL. We identified a significant decrease in the geometric mean VL, from 567 copies/mL in 2007 to 90 copies/mL in 2012, and a corresponding increase in the percent of individuals with a suppressed VL, from 57% to 75% (both ptrend<0.0001). Population groups significantly less likely to have a suppressed VL were younger individuals, those of black race or Hispanic ethnicity, men who have sex with men [92% of whom were black or Hispanic], and perinatally-infected individuals. In adjusted analyses, only age and race/ethnicity remained as significant barriers to suppression. Increases in VL suppression occurred across most subgroups, including those traditionally believed to be less engaged in care such as injection drug users, but were less consistent among those age 13-24 (pinteraction=0.05). Conclusions: In this high HIV prevalence area, population-wide HIV prevention strategies, including implementation of expanded treatment guidelines, coincided with improvement in community viral load among most groups. More attention is needed to address continued disparities in the care continuum in the Bronx, particularly among young people.